![Mark Gardner](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark Gardner
Directeur/Membre du Conseil chez OmniSeq, Inc.
Profil
Mark Gardner currently works at OmniSeq, Inc., as Director from 2019 and Pleno, Inc., as Director from 2022.
Postes actifs de Mark Gardner
Sociétés | Poste | Début |
---|---|---|
OmniSeq, Inc.
![]() OmniSeq, Inc. Medical/Nursing ServicesHealth Services OmniSeq, Inc. operates molecular diagnostic laboratory. It offers two NGS-based assays: Immune Report CardSM and OmniSeq ComprehensiveSM. The company was founded by Carl Morrison in 2015 and is headquartered in Buffalo, NY. | Directeur/Membre du Conseil | - |
Pleno, Inc.
![]() Pleno, Inc. Internet Software/ServicesTechnology Services Pleno, Inc. is a company that specializes in multi-omic instrument platform technology for clinical testing and biomedical research. The company is based in San Diego, CA and was founded by Pieter van Rooyen, who has been the CEO since incorporation. The company's proprietary hypercoding™ technology uses signal processing techniques to provide targeted biological information with exceptional scale, precision, and performance. | Directeur/Membre du Conseil | 09/11/2022 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
OmniSeq, Inc.
![]() OmniSeq, Inc. Medical/Nursing ServicesHealth Services OmniSeq, Inc. operates molecular diagnostic laboratory. It offers two NGS-based assays: Immune Report CardSM and OmniSeq ComprehensiveSM. The company was founded by Carl Morrison in 2015 and is headquartered in Buffalo, NY. | Health Services |
Pleno, Inc.
![]() Pleno, Inc. Internet Software/ServicesTechnology Services Pleno, Inc. is a company that specializes in multi-omic instrument platform technology for clinical testing and biomedical research. The company is based in San Diego, CA and was founded by Pieter van Rooyen, who has been the CEO since incorporation. The company's proprietary hypercoding™ technology uses signal processing techniques to provide targeted biological information with exceptional scale, precision, and performance. | Technology Services |